Live feed08:02:06·530dSECFilingvia QuantisnowBarinthus Biotherapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.BRNS· Barinthus Biotherapeutics plcHealth CareOriginal source
